Natalie Powell - Centuria Capital Chief Officer
| CNI Stock | 1.95 0.04 2.09% |
Executive
Natalie Powell is Chief Officer of Centuria Capital
| Address | Chifley Tower, Sydney, NSW, Australia, 2000 |
| Phone | 61 2 8923 8923 |
| Web | https://www.centuria.com.au |
Centuria Capital Management Efficiency
The company has return on total asset (ROA) of 0.0352 % which means that it generated a profit of $0.0352 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0705 %, meaning that it generated $0.0705 on every $100 dollars invested by stockholders. Centuria Capital's management efficiency ratios could be used to measure how well Centuria Capital manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Centuria Capital's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 3.6 B in 2024, whereas Non Current Liabilities Total is likely to drop slightly above 340.4 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Niv Fernando | Hansen Technologies | N/A | |
| Wai Chi | Medical Developments Internatio | N/A | |
| Peter Beamsley | Hansen Technologies | N/A | |
| Veronique MorganSmith | Mach7 Technologies | N/A | |
| Kara Boden | Clime Investment Management | N/A | |
| Andrew Selim | Healthco Healthcare and | N/A | |
| Stefaan Schatteman | Medical Developments Internatio | N/A | |
| Tushar Kale | Clime Investment Management | N/A | |
| David Madaffri | Mach7 Technologies | N/A | |
| Kerry Thomas | Clime Investment Management | N/A | |
| Angelo Konstantinou | Viva Leisure | N/A | |
| Matthew Cramer | Medical Developments Internatio | N/A | |
| Richard English | Hansen Technologies | N/A | |
| Scott Courtney | Medical Developments Internatio | N/A | |
| Christian Soberg | Healthco Healthcare and | N/A | |
| Simon Dutton | Clime Investment Management | N/A | |
| Malcolm McNab | Hansen Technologies | N/A | |
| Abarna Meecham | Healthco Healthcare and | N/A | |
| Andrew Dodds | Healthco Healthcare and | N/A | |
| Greer Lucas | Medical Developments Internatio | N/A | |
| Jennie Bian | Healthco Healthcare and | N/A | |
Management Performance
| Return On Equity | 0.0705 | ||||
| Return On Asset | 0.0352 |
Centuria Capital Leadership Team
Elected by the shareholders, the Centuria Capital's board of directors comprises two types of representatives: Centuria Capital inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Centuria. The board's role is to monitor Centuria Capital's management team and ensure that shareholders' interests are well served. Centuria Capital's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Centuria Capital's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Victor Georos, Head Management | ||
| Andrew Essey, Head Transactions | ||
| Natalie Powell, Chief Officer | ||
| Brad Watson, Head Distribution | ||
| John McBain, Joint Director | ||
| Ross Lees, Head Management | ||
| BComm BCom, Joint Director | ||
| Thomasina Ralston, Head Marketing | ||
| Simon Holt, Chief Officer | ||
| Alexandra Koolman, General Communications | ||
| Tim Mitchell, Group Relations | ||
| Andr Bali, Head Development | ||
| Michael Blake, Head Life | ||
| Emily Smith, Head Operations |
Centuria Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Centuria Capital a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0705 | ||||
| Return On Asset | 0.0352 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.52 % | ||||
| Current Valuation | 817.81 M | ||||
| Shares Outstanding | 830.09 M | ||||
| Shares Owned By Insiders | 20.35 % | ||||
| Shares Owned By Institutions | 31.27 % | ||||
| Price To Book | 1.07 X | ||||
| Price To Sales | 4.95 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Centuria Stock Analysis
When running Centuria Capital's price analysis, check to measure Centuria Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centuria Capital is operating at the current time. Most of Centuria Capital's value examination focuses on studying past and present price action to predict the probability of Centuria Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centuria Capital's price. Additionally, you may evaluate how the addition of Centuria Capital to your portfolios can decrease your overall portfolio volatility.